The University of Texas School of Public Health at Houston 1200 Pressler st, RAS E717 Houston, Texas 77030

Transcription

1 CURRICULUM VITAE Lu-Yu Hwang, M.D. I. GENERAL BIOGRAPHICAL INFORMATION A. Personal Mailing Address: The University of Texas School of Public Health at Houston 1200 Pressler st, RAS E717 Houston, Texas Address: Telephone/Voice Mail: (713) B. Current Position(s) Professor, Department of Epidemiology, Human Genetics,,and Environment Science, The University of Texas, School of Public Health at Houston Th Director, Laboratory of Virology and STD Research, Center for Infectious Diseases, The University of Texas, School of Public Health at Houston December 8, 2014 Adjunct Professor, Department of Epidemiology, Division of Cancer Prevention, The University of Texas M.D. Anderson Cancer Center at Houston C. Education and Training 1. Undergraduate/Graduate Education National Taiwan University, Medical College, Taiwan, Republic of China, M.B.B.S. (M.D. equivalent), Postgraduate Training Resident, Pediatrics, National Taiwan University Hospital, Taiwan, Research Fellow, Epidemiology and Clinical Investigation, University of Washington Medical Research Unit (UWMRU), American University Medical Research Center, Taipei, Taiwan, Certifications and Licenses US Educational Commission for Foreign Medical Graduates (ECFMG), 1974 Diplomat Medicine of Republic of China (Physician License), 1976 The Pediatric Association of the Republic of China, (Board of Pediatrics), 1978 US Medical Board FLEX Examination, Component 1(1986), Component 2(1992) Infectious Disease Society of America, 1987 American College of Epidemiology, 1993 D. Academic Appointments

2 Professor (tenured,1996), Department of Epidemiology, Human Genetics,,and Environment Science The University of Texas, School of Public Health at Houston, 2007-present Director, Laboratory of Virology and STD Research (former Hepatitis/HIV Research), Center for Infectious Diseases, The University of Texas, School of Public Health at Houston, 1993-present Professor, Infectious Diseases and Virology/Gene Therapy Program, The University of Texas, Graduate School of Biomedical Science at Houston, Associate Professor (tenured,1996), Division of Epidemiology and Disease Control, The University of Texas, School of Public Health at Houston, Associate Professor, Infectious Diseases and Virology/Gene Therapy Program, The University of Texas, Graduate School of Biomedical Science at Houston, Adjunct Associate Professor, Department of Epidemiology, Division of Cancer Prevention, The University of Texas M.D. Anderson Cancer Center at Houston, Visiting Professor, Xi an Jiaotong University, and Nanjing University, China, Associate Professor, Associate Professor,(cross appointment), Department of Pediatrics, University of Texas Medical School at Houston, Assistant Professor, Human Genetic Center, The University of Texas, Graduate School of Biomedical Science at Houston, Assistant Professor, (cross appointment), Epidemiology Discipline, The University of Texas, School of Public Health at Houston, Assistant Professor, (cross appointment), Department of Pediatrics, The University of Texas Medical School at Houston, Adjunct Assistant Professor, Department of Epidemiology, The university of Texas M.D. Anderson Cancer at Houston Visiting Associate Professor, Department of Microbiology & Immunology, National Yang Ming Medical College, Taipei, Taiwan, Assistant Research Professor, Department of Pediatrics and Laboratory Medicine, The University of California at San Francisco, CA, Assistant Research Professor, Department of Epidemiology, The University of Washington, School of Public Health, Seattle, WA, Associate Director and Investigator, The American University Medical Research Center, Taipei, Taiwan, December 8,

3 E. Past Clinical Appointments Department of Pediatrics, The University of California at San Francisco, California, Department of Pediatrics, The- National Taiwan University Hospital, Taipei, Taiwan, F. Professional Societies USA American College of Epidemiology (ACE) American Public Health Association (APHA) Infectious Diseases Society of America (IDSA) North America Professor Taiwanese Association (NAPTA) Society for Epidemiologic Research (SER) Society for Chinese Bioscience Association (SCBA) Texas Medical Association & Harris County Medical Society International Asian Pacific Association for the Study of the Liver International AIDS Society Taiwan, Republic of China Chinese Society of Microbiology and Immunology Formosan Medical Association Gastroenterological Society of the Republic of China Pediatric Association of the Republic of China G. Honors and Awards Excellence in Research Incentive Award, UTSPH Excellence in Research Incentive Award, UTSPH Excellence in Research Incentive Award, UTSPH Excellence in Research Incentive Award, UTSPH - Dean s Teaching Excellence Award, UTSPH Excellence in Research Incentive Award, UTSPH - Excellent in Teaching Incentive Award; UTSPH Excellence in Research Incentive Award, UTSPH 2006-James H. Nakano Citation Award from the National Center for Infectious Diseases of the Centers for Disease Control and Prevention; Excellence in Research Incentive Award, UTSPH Excellence in Research Incentive Award, UTSPH 2004-Excellence in Research Incentive Award, UTSPH 2003-Excellence in Research Incentive Award, UTSPH December 8,

4 2002-Excellence in Research Incentive Award, UTSPH - Excellence in Scholarship (Teaching) Incentive Award; UTSPH Excellence in Research Incentive Award, UTSPH - Excellence in Scholarship Incentive Award; UTSPH Excellence in Scholarship (Teaching) Incentive Award, UTSPH Excellence in Research Incentive Award, Excellence in Scholarship (Teaching) Incentive Award; UTSPH 1999-Dean s Teaching Award, UT Graduate School of Biomedical Science 1998-Excellence in Research Incentive Award, UTSPH 1997-Excellence in Research Incentive Award, UTSPH; 1997-Dean s Teaching Award, UT Graduate School of Biomedical Science Excellence in Research Incentive Award, UTSPH 1995-Excellence in Research Incentive Award, UTSPH; 1995-Dean s Teaching Award, UT Graduate School of Biomedical Science 1993-Dean s Teaching Award, UT Graduate School of Biomedical Science 1990-Outstanding Leadership Award, Over the Hill Inc. Houston, Texas, 1978-Mead Johnson Pediatric Research Awards, 1978 II. RESEARCH INFORMATION A. Current, and Past and Research Support Active. Co-Investigator (5%), The feasibility of self/partner-assisted digital anal exams for cancer screening. NCI, R21 (1R21CA181901), project period of ((Principal Investigator: R. Alan G. Nyitray, PhD) Co-Investigator (5%),YMAP: Young Men s Affiliation Project of HIV Risk and Prevention Venues NIH/NIMH (1R01MH100021) project period of (Principal Investigator: Kayo Fujimoto, PhD Co- Investigator (2.5%), Genome Wide Associate Study of hepatocellular carcinoma, National Cancer Institute, 1R01CA A1, Project period of (Principal Investigator: Manal Hassan, MD PhD of MDACC.) Completed Training Grants: Mentor CPRIT FMS# Collaborative Training of A New Cadre of Innovative Cancer Prevention Researchers (PI: P Mullan and R. Ness, UTSPH). Budget: $2,617,614 (6/18/ /17/2013). NIH/Fogarty International Center 5D43TW S2 CITAR The UTSPH Program for Advanced Training on AIDS Research, Mentor (PI: Palmer December 8,

5 Beasley/Lu-Yu Hwang). Budget: $1,674,377 (6/1/2006-8/31/2013). Completed Research Grants Consultant (2%), Innovative strategies for breast cancer immunotherapy, funded by Department of Defense to MDACC for 9/30/ /29/2013. Principle Investigator: Feng Wang-Johanning, MD, PhD of MD Anderson Cancer Center, Department of immunology Principle investigator (10%), Technology-based Intervention to improve treatment adherence for people living with HIV infection in Vietnam. National Institute of Health/Fogarty International Center; (#1D43 TW007669) supplement. Total cost of $92,593 for period 6/1/2012-8/31/2013 Director and principal investigator (10%), Center for International Training on AIDS Research (CITAR)-The UTSPH Program for Advanced Training on AIDS Research, National Institute of Health/Fogarty International Center; (#1D43 TW007669), Total cost of $279,482 for project period:8/15/2011-8/31/2013. (Principal Investigator: R. Palmer Beasley, MD, 7/1/2006-5/31/2012 (Proj ID: ) Associate Director and Co-investigator (5%), Center for International Training on AIDS Research (CITAR)-The UTSPH Program for Advanced Training on AIDS Research, National Institute of Health/Fogarty International Center; (#1D43 TW007669), Total cost of $1,415,075 for project period:7/1/2006-6/30/2011. (Principal Investigator: R. Palmer Beasley, MD) Co-investigator and collaborator (5%), Determine Whether HIV Transient Infection Occurs, National Institutes of Allergy and Infectious Diseases,(NIAID#5R01A ). Total cost of 1,868,416 for project period: 12/1/ /30/2010. (Principal Investigator: Miles Cloyd, PhD of UTMB) Principal Investigator (5%) of the supplement subcontract from UTMB, Total cost of 150,000 for project period :8/1/2008-7/31/2011. Ruth L.Kirschstein National Research Service Award Postdoctoral Fellowship (F32). Close Relationships and HIV Risk among Inner-City Drug Users. National Institute of Drug Abuse, Project period: 1/1/08-12/31/10 (Principal Investigator Follow: :Eric A. Ratliff, PhD). Principal Investigator (25%), A Hepatitis B Vaccination Model for HIV vaccine trials in drug user, National Institute of Drug Abuse (NIDA# 1R01DA017505). Total cost of $3,397,721 for project period: 07/01/ /30/ Principal investigator (5%), Evaluating Potential Exposure to Blood and Risk of HCV in Persons without Traditional Risk Factors, Centers for Disease Control & Prevention (CDC #U50/CCU616922). Total cost of $300,000 for project period: 09/1/1999-8/31/ Principal Investigator (10%), Perinatal and Household Transmission of HCV, , Centers for Disease Control & Prevention (CDC #U50/CCU615187). Total cost of $604,670 project period: 09/01/1997-8/31/ Co-Principal Investigator (5%), Crack Cocaine Use as a Major Risk for HIV Transmission, Texas Department of Health (TCADA). Total cost of $ 73,000 for project period: 09/01/1996-8/31/1999. December 8,

6 Co-Principal Investigator (10%), Syphilis Prevention in Houston, Texas, Centers for Disease Control & Prevention (CDC #R30/CCR612016) Total cost of $ 1,583,690 for project period of 09/01/1995-8/31/2000. (Principal Investigator, Michael Ross, PhD).. Principal Investigator (5%), Prevalence of Markers for STDs in Homeless Youth, Houston Institute for Protective Youth, Total cost of $4,105.75, for project period: Principal Investigator (5%), Household Survey on Anti-HCV Positive Pregnant Women, Centers for Disease Control & Prevention (supplement of CDC # ). Total cost of $118,530 for project period: 09/01/1994-8/31/ Principal Investigator (12.5%), Multi-Center Study to Assess the Risk and Consequences of Hepatitis C Virus (HCV) Transmission from Mothers to Infants, , Centers for Disease Control & Prevention (CDC # ) Total cost of $ 939,642 for project period of 09/01/1993-8/31/ Principal Investigator (10%), Study Factors Associated with Perinatal Transmission of HIV - Part of State Perinatal AIDS Project. State of Texas, $ 100,000 per year for project period: Principal Investigator (10%), Evaluation of Minority and Community-Based HIV Prevention Project. Over the Hill Inc. via Center for Disease Control and Prevention, Total cost of $121,543 for 09/01/1989-8/31/1991. Co-investigator and Education Program Development & Epidemiology Consultant (15%), Training Grant for AIDS Regional Education and Training Center, Human Resource and Administration Service (HRAS). Total cost of $3,000,000 for project period of 09/01/1988-8/31/1991. (Principal Investigator: Richard Grimes, Ph.D.). Co-Principal Investigator, Genetic Determinants of Outcome in HBV Infections- Taiwan Project. National Cancer Institute, Total cost of $ 60,000 for project period; ; and total cost of $50,000 for project period: (Principal Investigator: R. Palmer Beasley, M.D.) Co-Principal Investigator, Recombinant Hepatitis B Vaccine - immunogenicity in infants-taiwan Project. Merck Sharp & Dohme Research Laboratories, Total cost of $248,550 for project period: (Principal Investigator: R. Palmer Beasley, M.D.) Co-Principal Investigator, Long-term Follow-up of HBV Vaccines in Children-Taiwan Project. National Science Council, Taiwan. Total cost of $350,000 for project period of (Principal Investigator: R. Palmer Beasley, M.D.) Co- Principal Investigator, Alfa-fetal Protein Screening among HBsAg Carriers for Detection of Small Hepatocellular Carcinoma-Taiwan Project, National Health Ministry & National Science Council, Taiwan. Project period (Principal Investigator: R. Palmer Beasley, M.D.) B. Pending Research Support. Co-Investigator (5%), Integrated Molecular and Affiliation Network Analysis of HIV Transmission. NIH, R21, project period of (Principal Investigator: Kayo December 8,

7 Fujimoto, PhD) C. Publications Multi-Principal Investigator (15%), CITAR-HanoiSPH for Advanced Training on HIV Research. National Institute of Health/Fogarty International Center, Project period of (Multi-Principal Investigator: Lu-Yu Hwang, MD) Journals (Peer reviewed): student author indicated by underline leadership role indicated by asterisk* 1. Hwang LY, Lue HC: Total anomalous pulmonary venous return - clinical analysis of 15 cases. Acta Pediat Sinica, 19:26-35, Hwang LY, Lee CY, Shen YZ: Purulent meningitis in children - part I. Epidemiology and clinical analysis of 287 cases. Acta Pediat Sinica, 19: , Hwang LY, Shen YZ, Lee CY: Purulent meningitis in children - part II. A long- term neurological follow-up study. Acta Pediat Sinica, 19: , Chen SH, Hwang LY, Wu HS, Huang SZ, Chen CH, Lee TC: Serum thyroxin, triodothyronine, T3 uptake and thyroid stimulating hormone concentrations in infancy, childhood, adolescence and pediatric thyroid disorders. Journal of Formosan Medical Association, 79: , PMID: R. Palmer Beasley, Lu-Yu Hwang, Chia-Chin Lin, Cladd E. Stevens, Kwei-Yun Wang, Tsu-Shen Sun, Fong-Jou Hsieh, Wolf Szmuness: Hepatitis B immune globulin (HBIG) efficacy in the interruption of perinatal transmission of hepatitis B virus carrier state. Lancet, 2: , PMID: R. Palmer Beasley, Lu-Yu Hwang, Chia-Chin Lin, and Chia-Siang Chien: Hepatocellular carcinoma and HBV: A prospective study of 22,707 men in Taiwan. Lancet, 2: , PMID: R. Palmer Beasley, Chia-Chin Lin, Lu-Yu Hwang (1981): The risk of hepatocellular carcinoma in hepatitis B virus infections: a prospective study in Taiwan.. In: W Szmuness, HJ Alter, JE Maynard (eds.), Viral Hepatitis, 1981 International Symposium, The Franklin Institute Press, Philadelphia, PA, p Cladd E. Stevens, R. Palmer Beasley, Chia-Chin Lin, Lu-Yu Hwang, Tsu-Sen Sun, Fong-Jo Hsieh, Kwei-Yun Wang, Wolf Szmuness (1981): Perinatal hepatitis B virus infection: use of hepatitis B immune globulin. In: W Szmuness, HJ Alter, JE Maynard (eds.), Viral Hepatitis, 1981 International Symposium, The Franklin Institute Press, Philadelphia, PA, p Lu-Yu Hwang: Hepatitis B vaccine. Current Medical Digest, 69:5-19, 70:7-15, R. Palmer Beasley, and Lu-Yu Hwang: Measles vaccination not interfered with by hepatitis immune globulin. Lancet, 1:161, PMID: R. Palmer Beasley, I-Sen Shiao, Tzee-Chung Wu, Lu-Yu Hwang: Hepatoma in an HBsAg carrier - 7 years after perinatal infection. Journal of Pediatrics, 101:83-84, PMID: December 8,

8 12. R. P. Beasley, L.-Y Hwang, C.-C. Lin, M.-L Leu, C.E. Stevens, W. Szmuness, and K.-P Chen: Incidence of hepatitis B virus infections in preschool children in Taiwan. Journal of Infectious Disease, 146: , PMID R. Palmer Beasley, Chia-Chin Lin, Chia-Siang Chien, Chien-Jen Chen, and Lu-Yu Hwang: Geographic distribution of HBsAg carriers in China. Hepatology, 2: , PMID: R. Palmer Beasley, and Lu-Yu Hwang (1982): Non-A non-b hepatitis in Taiwan. In: F Deinhardt ed. Viral hepatitis: Second International Max von Pettenkofer Symposium, The Marcel Dekker, Inc., p R. Palmer Beasley, and Lu-Yu Hwang (1982): Vaccine studies in Chinese children in Taiwan. In: F Deinhardt ed. Viral Hepatitis: Second International Max von Pettenkofer Symposium. The Marcel Dekker, Inc., p Beasley RP, Hwang LY, Szmuness W, Stevens CE, Lin CC, Hsieh FJ, Wang KY, Sun TS. HBIG prophylaxis for perinatal HBV infections--final report of the Taiwan trial Dev Biol Stand. 1983;54: PMID: R. Palmer Beasley, Lu-Yu Hwang, Chia-Chin Lin, Yuan-Chin Ko, Shing-Jer Twu: Incidence of hepatitis among students at a university in Taiwan. American Journal of Epidemiology, 117: , PMID R. Palmer Beasley, and Lu-Yu Hwang: Postnatal infectivity of HBsAg carrier mothers. Journal of Infectious Disease, 147: , PMID Lu-Yu Hwang, R. Palmer Beasley, Czau-siung Yang, Liang-chu Hsu, Kung-pei Chen: Incidence of hepatitis A virus (HAV) infections in children in Taiwan. Intervirology, 20: , PMID: Lu-Yu Hwang, R. Palmer Beasley, Cladd E. Stevens, and the late Wolf Szmuness:: Immunogenicity of HBV vaccine (Hepatavax B) II. Response of healthy Chinese children. Vaccine, 1:10-12, PMID: George Chiun-Yun Lee, Lu-Yu Hwang, R. Palmer Beasley, Shen-Hyi Chen, and Tzu- Yao Lee: Immunogenicity of HBV vaccine in healthy Chinese newborns. Journal of Infectious Disease, 148: , PMID: R. Palmer Beasley, Lu-Yu Hwang, Cladd E. Stevens, Chia-Chin Lin, Fon-Jou Hsieh, Kwei-Yu Wang, Tsu-Shen Sun, and Wolf Szmuness: Efficacy of hepatitis B Immune Globulin (HBIG) for prevention of perinatal transmission of the HBV carrier state: Final report of a randomized double-blind placebo controlled trial. Hepatology, 3: , PMID: R. Palmer Beasley, Lu-Yu Hwang, George Chin-Yun Lee, Chung-Chi Lan, Chen- Hsiung Roan, Fu-Yuan Huang, Chiung-Lin Chen: Prevention of perinatally transmitted hepatitis B virus infections with hepatitis B immune globulin (HBIG) in combination with HB vaccine first report of a randomized controlled trial. Lancet, 2: , PMID: R. Palmer Beasley, and Lu-Yu Hwang: Immunogenicity of HBV vaccine (Hepatavax B): Response of healthy adults. Western Journal of Medicine, 140: , PMID: PMCID: PMC December 8,

9 25. R. Palmer Beasley, and Lu-Yu Hwang: Hepatocellular carcinoma and hepatitis B Virus. Seminars in Liver Disease, 4: , PMID: R. Palmer Beasley, and Lu-Yu Hwang (1984) : Epidemiology of hepatocellular carcinoma. in GN Vyas, JL Dienstag, JH Hoofnagle (eds.), Viral Hepatitis and Liver Disease, Grune and Stratton, Inc., Florida, p R. Palmer Beasley, Lu-Yu Hwang (1984): Current status of hepatitis B vaccination in children. In SK Lam, CL Lai, EK Yeoh (eds.), Viral Hepatitis B Infection in the Western Pacific Region: Vaccine and Control, Hong Kong, p Lu-Yu Hwang, Michael Roggendorf, R. Palmer Beasley, and Friedrich Deinhardt: Perinatal transmission of hepatitis B virus: Role of maternal HBeAg and Anti-HBc IgM. Journal of Medical Virology, 15: , PMID: Jen-Yang Chen, Lu-Yu Hwang, R. Palmer Beasley, Chia-Shiang Chien, Czau-Siung Yang: Antibody response to Epstein- Barr Virus-Specific DNase in thirteen patients with nasopharyngeal carcinoma in Taiwan: A retrospective study. Journal of Medical Virology, 16:99-105, PMID: Hey-Chi Hsu, Jin-Chuan Sheu, Yun-Ho Lin, Ding-Shinn Chen, Chue-Shue Lee, Lu-Yu Hwang, and R. Palmer Beasley: Prognostic histological features of resected small hepatocellular carcinoma (HCC) in Taiwan: A comparison with resected large HCC. Cancer, 56: , PMID: R. Palmer Beasley, and Lu-Yu Hwang: Abnormal immunologic response to hepatitis B in two brothers: A genetic effect? Journal of Infectious Disease, 152(6):1356, PMID: Nunilon E. Sy, Virginia Basaca-Sevilla, Tagumpay Esguerra, R. Palmer Beasley, Lu-Yu Hwang, and John H. Cross: HBsAg and HBeAg markers among pregnant women in Manila, Philippines. Transactions of the Royal Society of Tropical Medicine and Hygiene, 80: , PMID: Chu-Shue Lee, Jue-Low Sung, Lu-Yu Hwang, Jin-Chuan Sheu, Ding-Shinn Chen, Tien-Yu Lin, and R. Palmer Beasley: Surgical treatment of 109 cases of symptomatic and asymptomatic hepatocellular carcinoma. Surgery, 99(4): , PMID: Fen-Fen Wu, Lu-Yu Hwang, Chiun-Yun Lee, Chiun-Yun Hsu, Chiun-Fu Chen, His- Ping Kau, and R. Palmer Beasley: Primary evaluation of nationwide immunization against hepatitis in high risk infants. Journal of Formosan Medical Association, 86: , PMID: Michael Roggendorf, Lu-Yu Hwang, R. Palmer Beasley, Pao-Huei Chen, Tong-Chau Chen, Kwan-Re Lo, and Friedrich Deinhardt: Anti- HBc IgM in hepatocellular carcinoma and cirrhosis in Taiwan. Journal of Hepatology, 5: , PMID: Mei-Hwei Chang, Lu-Yu Hwang, Hey-Chi Hsu, Chin-Yun Lee, and R. Palmer Beasley: Prospective follow-up of asymptomatic hepatitis B virus carrier children infected in the perinatal period: Clinical and liver histological studies. Hepatology, 8:374-7, PMID: December 8,

10 37. Ernest Song, Michael Kew Lu-Yu Hwang, and R. Palmer Beasley: Epidemiology of hepatitis B in South African Chinese. American Journal of Epidemiology, 128: , PMID: Chu-Shue Lee, Lu-Yu Hwang, R. Palmer Beasley, Hey-Chi Hsu, Hau-Shan Lee, and Tien-Yu Lin: Prognostic factor for small hepatocellular carcinoma patients. Acta Chirugica Scandinavia, 154: , PMID: Lu-Yu Hwang, R. Palmer Beasley: Hepatitis B virus - the major etiology of hepatocellular carcinoma. Cancer Bulletin, 40: , L. Y. Hwang, R.P. Beasley, M.P. Busch, P.K. Lane, and G.N. Vyas: Human Immunodeficiency virus seroprevalence among blood products recipients prior to transfusion in San Francisco. Transfusion, 29: , PMID: Jen-Yang Chen, Chien-Jen Chen, Mei-Ying Liu, Show-Mei Cho, Mow-Ming Hsu, Tsong-Chou Lynn, Ti Shie, Shie-Mien Tu, R. Palmer Beasley, Lu-Yu Hwang, Hong- Hsin Lee, Shiow-Ling Kuo, and Czau-Siung Yang: Antibody to Epstein-Barr virusspecific DNase as a marker for field survey of patients with nasopharyngeal carcinoma in Taiwan. Journal of Medical Virology, 27: , PMID: Chin-Yun Lee, Lu-Yu Hwang, R. Palmer Beasley: Low-Dose hepatitis B vaccine. Lance, ii: , PMID: Lu-Yu Hwang, Chin-Yun Lee, R. Palmer Beasley (1990): Five year follow-up of HBV vaccination with plasma derived vaccine in neonates: evaluation of immunogenicity and efficacy against perinatal transmission. In: FB Hollinger, SM Lemon, HS Margolis (eds.), Viral Hepatitis -1990, The Williams & Wilkins, p R. Palmer Beasley and Lu-Yu Hwang (1990): Overview on the Epidemiology of Hepatocellular Carcinoma. In: FB Hollinger, SM Lemon, HS Margolis (eds.), Viral Hepatitis -1990, The Williams & Wilkins, p Chin-Yun Lee, Lu-Yu Hwang, R. Palmer Beasley, Chiun-Fu Chen, Fu-Yan Huang, Shou-Chen Wu, Chong-Chi Lan (1990): Immunogenicity and protective efficacy on low-dose hepatitis B vaccine in newborns of HBsAg-carrier mothers. In: FB Hollinger, SM Lemon, HS Margolis (eds.), Viral Hepatitis -1990, The Williams & Wilkins, p Lu-Yu Hwang: Specific Travel Concerns: Pediatric Prophylaxis, Diagnosis, and Treatment of Hepatitis A, B, C, D and E. Seminar in Pediatric Infectious Disease, 3: 1-36, Robert D. Burk, Lu-Yu Hwang, Gloria Y.F. Ho, David A Sharfritz, and Palmer Beasley: Outcome of perinatal hepatitis B virus exposure is dependent on maternal viral load. Journal of Infectious Disease, 170: , PMID: Dean M, Stephensn JC, Winkler C, Lomb D, Ramsburg M, Boaze R, Stewart C, Charbonneau L, Goldman D, Albaugh B, Geodert J, Beasley RP, Hwang LY, Buckbinder S, Kaslow R, Obrams I, Gomperts E, Dondield S, Johnson P, Eichelberger M & O'Brien S: Polymorphic admixture typing in human ethnic populations. American Journal of Human Genetics, 55: , PMCID: PMC Risser, J., Rabeneck, L., Hwang, L.-Y: A Comparison of Population-Specific Fat- December 8,

11 Free Mass and Body-Cell Mass Prediction Equations in HIV-Infected Men. Journal of the American Dietetic Association 95, Issue 9 SUPPL.1995, Pages A15 50 J.M.H. Risser; L. Rabeneck; L.-Y. Hwang, Anti-viral medication is protective of lean body mass in a cross sectional study of wasting in hiv-infected men, Journal of Investigative Medicine, 44 (3): 251, 1996, Pages 251a 51 Nathaniel H Smith, and Lu-Yu Hwang*: Risk Factors for HIV in pregnant women. International Journal of STDs and AIDS, 7: , PMID: William L. Risser, and Lu-Yu Hwang*: Problems in the current case definition of congenital syphilis. Journal of Pediatrics, 129: , PMID: William L. Risser, and Lu-Yu Hwang*: Congenital syphilis in Harris County, TX : surveillance, diagnosis, incidence, & risk. International Journal of STDs and AIDS, 8: , PMID: Snachit Maruti, Lu-Yu Hwang*, Michael Ross, Lori Leonard, John Paffel, and Linda Hollins: Epidemiology of early syphilis in Houston, Texas, Journal of Sexual Transmitted Diseases, 24: , PMID: Rachel L. Richesson, Lu-Yu Hwang*: The impact of the 1993 expanded CDC AIDS surveillance case definition in Texas. Texas Medicine, 94:56-63, PMID: Xifeng Wu, Jun Gu, Yehuda Patt, Manal Hassan, Margaret R. Spitz, R. Palmer Beasley, and Lu-Yu Hwang*: Mutagen sensitivity as a susceptibility marker for human hepatocellular carcinoma. Cancer Epidemiology and Biomarkers Prevention, 7: , PMID: Yetman RJ, Risser WL, Barth BA, Risser JM, Hwang LY: Problems in physician classification and reporting of congenital syphilis. International Journal of STDs and AIDS, 9: 765-8, PMID: Michael Ross, Lu-Yu Hwang, Lori Leonard, Ming Teng and Lawrence Duncan: Sexual behavior, STDs and Crack Cocaine Use in a Crack House Population. International Journal of STDs and AIDS, 10: , PMID: M. Cecilia Di Pentima, Lu-Yu Hwang*, Claire M. Skeeter, and MorvenEdwards: Prevalence of Trypansoma Cruzi infection (Chagas Disease) among Hispanic pregnant women in Houston TX. Clinical Infectious Diseases, 28:1281-5, PMID: Judy S. Wu, Lu-Yu Hwang*, Karen Goodman, and R. Palmer Beasley: Hepatitis B vaccination in high-risk infants: 10-year follow-up. Journal of Infectious Disease, 179: , PMID: Jan M.H. Risser, Lu-Yu Hwang*, William L. Risser, Linda Hollins, and John Paffel: The epidemiology of syphilis in the waning years of an epidemic: Houston, TX Journal of Sexual Transmitted Diseases, 26: , PMID: Catherine D Cooksley, Lu-Yu Hwang*, D. Kim Waller, and Charles Ford: HIV- Related Malignancy- a community based study using a linkage of cancer registry and HIV registry data. International Journal of STDs and AIDS, 12: , PMID: December 8,

12 63. Lu-Yu Hwang, Michael Ross, Carolyn Zack, Lara Bull, Kathie Rickman, and Marsha Holleman: The prevalence of sexually transmissible infections and associated risk factors in drug abuse populations. Clinical Infectious Diseases, 31:920-6, PMID: Manal Hassan,hr 64. Manal Hassan, Ashraf S. Zaghloul, Hashem B. El-Serag, Osama Soliman, Yehuda Patt, Cynthia L. Chappell, R. Palmer Beasley, and Lu-Yu Hwang*: The role of hepatitis C in hepatocellular carcinoma: A case-control study among Egyptian patients. Journal of Clinical Gastroenterology, 33(2): , PMID: Catherine D. Cooksley, Lu-Yu Hwang*, Charles E. Ford: Registry linkage to study cancer in persons infected with HIV. Journal of Registry Management, 28:82-88, Janet Baseman, Lori Leonard, Michael Ross, and Lu-Yu Hwang: Acceptance of syphilis screening among residents of high STD-risk Houston communities. International Journal of STDs and AIDS, 12: , PMID: Michael W Ross, Lu-Yu Hwang, LY, Carolyn Zack, Lara Bull, and Mark L Williams: Sexual risk behaviors and STIs in drug abuse treatment populations whose drug of choice is crack cocaine. International Journal of STDs and AIDS, 13: , PMID: Lyn Finelli, Thomas P. Farley, James J. Gibson, Carol Langley, Lu-Yu Hwang, and William C.Levine: Prevalence monitoring in syphilis surveillance: Results from a multi center research program. Sexually Transmitted Diseases, 29 (12): , PMID: Manal M. Hassan, 69. Manal M. Hassan,Lu-Yu Hwang*, Chiq J. Hatten, Mark Swaim, Donghui Li, James L. Abbruzzese, Palmer Beasley, and Yehuda Patt: Risk factors for hepatocellelar carcinoma: Synergism of alcohol with viral hepatitis and diabetes mellitus. Hepatology, 36: , PMID: G. D Souza G, 70. G G. D Souza G, R. Arafat, L. Hwang*, C. Cunningham, S Shah, and K. Reynolds:Crosssectional survey of the extent and indicators of hepatitis C virus infection in Houston Department of Health and Human Services STD clinics. Journal of Viral Hepatitis, 10: , PMID: F.T. O'Donnell, F.M. Munoz, R.L. Atmar, L.Y. Hwang, G.J. Demmler, and W.P. Glezen: Epidemiology And Molecular Characterization Of Co-Circulating Influenza A/H3n2 Virus Variants In Children: Houston, Texas, Epidemiology and Infection, 130: , PMID: Jennifer R. Kramer, 72. Jennifer R. Kramer, Thomas P. Giordano, Julianne Souchek, Peter Richardson, Lu-Yu Hwang*, and Hashem B. El-Serag: The effect of HIV co-infection on the risk of cirrhosis and hepatocellular carcinoma in US veterans with hepatitis C. American Journal of Gastroenterology, 100(1):56-63, PMID: Hua Zhao, H. Barton Grossman, George L. Delclos, Lu-Yu Hwang, Catherine Troisi, Robert M. Chamberlain, Marsha Chenoweth, Hulfeng Zhang, Margaret R. Spitz, Xifeng Wu: Increased plasma levels of angiogenin and risk of bladder cancer from initiation to recurrence. Cancer, (2005), 104(1):30-5. PMID: Kelvin Stancoven, Lu-Yu Hwang*, and Catherine Troisi: Significance of Anti-HBc in December 8,